CARLSMED Funding & Investors
Provider of medical technology for spine surgery. The company’s proprietary aprevo™ digital-to-device 3-D printed implant system for spine is first-ever surgical implant to be designated by the FDA as a breakthrough technology. Hospital and surgeon customers across the country choose aprevo™ for the benefits of personalized medicine in lumbar fusion surgery. Carlsmed was founded in 2018 and is headquartered in San Diego, California.
carlsmed.comTotal Amount Raised: $96,985,000
CARLSMED Funding Rounds
Series C
$52,500,000
Series C Investors
B CapitalUSVPSeries B
$30,000,000
Series B Investors
B CapitalWavemaker Three-Sixty HealthCove FundUSVPVertical GroupSeries A
$10,000,000
Series A Investors
USVPCove FundWavemaker Three-Sixty HealthVertical GroupSeed
$2,500,000
Seed Investors
Cove FundDevice of Tomorrow CapitalWavemaker Three-Sixty HealthDebt Financing
$1,985,000
Funding info provided by Diffbot.